Vallon Pharmaceuticals, Inc.
SEC CIK 1824293 · VLON · last insider filing 2025-09-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Szekeres David Leslie | Director | filed 2023 - 2025 |
| Rongen Roelof | Director | filed 2023 - 2025 |
| Simpson Camilla V | Director | filed 2023 - 2025 |
| Baker David Charles | Director · Chief Executive Officer | filed 2021 - 2025 |
| Hertz Walter Marc | Director · Chief Executive Officer | filed 2023 - 2025 |
| Thorell Marella | Director | filed 2021 - 2022 |
| Payne Joseph E | Director | filed 2021 - 2022 |
| Ammer Richard | Director | filed 2021 - 2022 |
| Chhabra Meenu | Director | filed 2022 - 2022 |
| Levi Ofir | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Kelly Leanne M. | Chief Financial Officer | filed 2021 - 2025 |
| Chaturvedi Vipin | Chief Scientific Officer | filed 2023 - 2025 |
| Agro Albert | Chief Medical Officer | filed 2023 - 2023 |
| Toren Penny | SVP, Regul Affairs & Prog Mgmt | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.